FIELD: veterinary science.
SUBSTANCE: present invention refers to veterinary medicine, namely to neuro-oncology. It can be used in radiation therapy of pituitary prolactinoma in rats. Method of treatment involves external beam therapy with irradiation of pituitary tumour with ionizing radiation. Irradiation is performed at depth of 15 mm with orientation of the cranial edge of the radiation field along the caudal border of eyeballs of the animal. Treatment is carried out in stages. At the first stage, two fractions are carried out on 1st and 7th day with a single absorbed dose of 10.0 Gy. If the radiation effect is insufficient, the second stage of treatment is carried out in 21 days, and the third fraction is performed with a single dose of 12.0 Gy.
EFFECT: method promotes improvement of quality and life expectancy of rats with pituitary prolactinoma.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
RADIATION CYSTITIS MODELING METHOD | 2018 |
|
RU2676431C1 |
METHOD FOR MODELING CHRONIC ISCHEMIA IN EXPERIMENTAL ANIMALS. | 2022 |
|
RU2777184C1 |
METHOD FOR PREVENTING AND TREATING ACUTE RADIATION INJURY | 2021 |
|
RU2770991C2 |
METHOD OF TREATING SQUAMOUS ORAL CANCER AND PHARYNX | 2019 |
|
RU2715550C2 |
METHOD FOR TREATMENT OF TRANSLABLE CONNECTIVE TISSUE SARCOMA M-1 IN RATS WITH COMBINED IMPACT OF PHOTODYNAMIC THERAPY AND RADIOTHERAPY | 2021 |
|
RU2763663C2 |
METHOD OF COMBINED RADIOTHERAPY AND PHOTODYNAMIC THERAPY | 2019 |
|
RU2724480C2 |
AGENT FOR PREVENTION OF CEREBRAL FORM OF ACUTE RADIATION SICKNESS | 2022 |
|
RU2797835C1 |
METHOD FOR TREATMENT OF RAT M-1 TRANSFERABLE CONNECTIVE TISSUE SARCOMA UNDER COMBINED IMPACT OF PHOTODYNAMIC THERAPY AND RADIATION THERAPY | 2021 |
|
RU2767272C2 |
METHOD FOR TREATING OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2018 |
|
RU2689875C2 |
METHOD FOR COMBINED TREATMENT OF LOCALLY ADVANCED FORMS OF CERVICAL CANCER IIB-IIIB (T2B-T3BN0(1)M0) STAGES | 2020 |
|
RU2748135C2 |
Authors
Dates
2024-10-21—Published
2024-06-26—Filed